Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3655)
All Articles published online
|
Jul 14, 2006 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang ZL, Liu ZS, Sun Q. Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma. World J Gastroenterol 2006; 12(26): 4241-4245 [PMID: 16830384 DOI: 10.3748/wjg.v12.i26.4241] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i26/4241.htm |
| Number | Citing Articles |
| 1 |
Wenjiao Zeng, Annette S.H. Gouw, Marius C. van den Heuvel, Peter J. Zwiers, Pieter E. Zondervan, Sibrand Poppema, Nong Zhang, Inge Platteel, Koert P. de Jong, Grietje Molema. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization. Hepatology 2008; 48(5): 1517 doi: 10.1002/hep.22490
|
| 2 |
Eline Vanheule, Anja M. Geerts, Jacques Van Huysse, Daphné Schelfhout, Marleen Praet, Hans Van Vlierberghe, Martine De Vos, Isabelle Colle. An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis. International Journal of Experimental Pathology 2008; 89(6): 419 doi: 10.1111/j.1365-2613.2008.00608.x
|
| 3 |
Thomas Yau, Pierre Chan, Roberta Pang, Kelvin Ng, S. T. Fan, Ronnie T. Poon. Phase 1‐2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma. Cancer 2010; 116(21): 5022 doi: 10.1002/cncr.25372
|
| 4 |
Roberta W. C. Pang, Jae Won Joh, Philip J. Johnson, Morito Monden, Timothy M. Pawlik, Ronnie T. P. Poon. Biology of Hepatocellular Carcinoma. Annals of Surgical Oncology 2008; 15(4): 962 doi: 10.1245/s10434-007-9730-z
|
| 5 |
Tomer Shlamkovich, Lidan Aharon, Dana Koslawsky, Yulia Einav, Niv Papo. Targeting the Tie2–αvβ3 integrin axis with bi-specific reagents for the inhibition of angiogenesis. BMC Biology 2018; 16(1) doi: 10.1186/s12915-018-0557-9
|
| 6 |
Paloma Sanz-Cameno, María Trapero-Marugán, María Chaparro, Evan Anthony Jones, Ricardo Moreno-Otero. Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma. Journal of Oncology 2010; 2010: 1 doi: 10.1155/2010/272170
|
| 7 |
Ann-Lii Cheng, Yoon-Koo Kang, Deng-Yn Lin, Joong-Won Park, Masatoshi Kudo, Shukui Qin, Hyun-Cheol Chung, Xiangqun Song, Jianming Xu, Guido Poggi, Masao Omata, Susan Pitman Lowenthal, Silvana Lanzalone, Liqiang Yang, Maria Jose Lechuga, Eric Raymond. Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial. Journal of Clinical Oncology 2013; 31(32): 4067 doi: 10.1200/JCO.2012.45.8372
|
| 8 |
Mohamed Bouattour, Audrey Payancé, Johanna Wassermann. Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging. World Journal of Hepatology 2015; 7(20): 2245-2263 doi: 10.4254/wjh.v7.i20.2245
|
| 9 |
Catherine Delbaldo, Camelia Colichi, Marie‐Paule Sablin, Chantal Dreyer, Bertrand Billemont, Sandrine Faivre, Eric Raymond. Polypharmacology in Drug Discovery. 2012; : 323 doi: 10.1002/9781118098141.ch16
|
| 10 |
Bart Vanderborght, Sander Lefere, Hans Van Vlierberghe, Lindsey Devisscher. The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma. Cells 2020; 9(11): 2382 doi: 10.3390/cells9112382
|
| 11 |
Maryam Hormozi, Saeed Talebi, Amir Hassan Zarnani, Mahmood Jeddi-Tehrani, Ladan Hosseini Gohari, Haleh Soltanghoraei, Mina Jafarabadi, Mohammad Mehdi Akhondi. 5′-(N-ethylcarboxamido) adenosine improves angiogenesis in transplanted human ovarian tissue. Fertility and Sterility 2011; 95(8): 2560 doi: 10.1016/j.fertnstert.2011.05.041
|
| 12 |
Hyungjoo Kim, Tae Sung Ahn, Chang-Jin Kim, Sang Byung Bae, Han Jo Kim, Chang-Seuk Lee, Tae Hyun Kim, Jungkyun Im, Sang Hun Lee, Myoung Won Son, Moon Soo Lee, Moo Jun Baek, Dongjun Jeong. Oncogenic function of angiopoietin-2 in vitro and its modulation of tumor progression in colorectal carcinoma. Oncology Letters 2017; 14(1): 553 doi: 10.3892/ol.2017.6203
|
| 13 |
Daniel H. Palmer, Matthew E. Cramp. Clinical Dilemmas in Primary Liver Cancer. 2011; : 199 doi: 10.1002/9781119962205.ch28
|
| 14 |
Ju Ik Moon, Jong Man Kim, Gum Oh Jung, Jae Min Chun, Gyu-Seong Choi, Jae Berm Park, Choon Hyuck David Kwon, Sung Joo Kim, Jae Won Jo. Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma. The Korean Journal of Hepatology 2008; 14(2): 185 doi: 10.3350/kjhep.2008.14.2.185
|
| 15 |
Ender G. Yegin, Aydos Siykhymbayev, Fatih Eren, Nural Bekiroglu, Osman Cavit Ozdogan. Prognostic implication of serum vascular endothelial growth factor in advanced hepatocellular carcinoma staging. Annals of Hepatology 2013; 12(6): 915 doi: 10.1016/S1665-2681(19)31297-9
|
| 16 |
Benjamin A. Lefkove, Levi E. Fried, Jack L. Arbiser. Clinical and Basic Immunodermatology. 2008; : 157 doi: 10.1007/978-1-84800-165-7_11
|
| 17 |
Adriana Romanzi, Fabiola Milosa, Gemma Marcelli, Rosina Maria Critelli, Simone Lasagni, Isabella Gigante, Francesco Dituri, Filippo Schepis, Massimiliano Cadamuro, Gianluigi Giannelli, Luca Fabris, Erica Villa. Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids. Biomedicines 2023; 12(1): 87 doi: 10.3390/biomedicines12010087
|
| 18 |
Yawen Zou, Ying Sun, Xinhua Chen, Liangjie Hong, Gang Dong, Xiwen Bai, Haiyu Wang, Benchen Rao, Zhigang Ren, Zujiang Yu. Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1163628
|
| 19 |
Valeria R. Mas, Daniel G. Maluf, Kellie J. Archer, Kenneth C. Yanek, Robert A. Fisher. Angiogenesis Soluble Factors as Hepatocellular Carcinoma Noninvasive Markers for Monitoring Hepatitis C Virus Cirrhotic Patients Awaiting Liver Transplantation. Transplantation 2007; 84(10): 1262 doi: 10.1097/01.tp.0000287596.91520.1a
|
| 20 |
L-Y Chen, X Liu, S-L Wang, C-Y Qin. Over-Expression of the Endocan Gene in Endothelial Cells from Hepatocellular Carcinoma is Associated with Angiogenesis and Tumour Invasion. Journal of International Medical Research 2010; 38(2): 498 doi: 10.1177/147323001003800213
|
| 21 |
Manzoor Ahmad Mir, Burhan ul Haq. Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies. 2022; : 249 doi: 10.1016/B978-0-443-18696-7.00008-7
|
| 22 |
Sandrine Faivre, Eric Raymond, Eveline Boucher, Jean Douillard, Ho Y Lim, Jun S Kim, Magaly Zappa, Silvana Lanzalone, Xun Lin, Samuel DePrimo, Charles Harmon, Ana Ruiz-Garcia, Maria J Lechuga, Ann Lii Cheng. Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study. The Lancet Oncology 2009; 10(8): 794 doi: 10.1016/S1470-2045(09)70171-8
|
| 23 |
Wojciech Naumnik, Elżbieta Chyczewska, Maria Ossolinska. Serum Levels of Angiopoietin-1, Angiopoietin-2, and Their Receptor Tie-2 in Patients with Nonsmall Cell Lung Cancer During Chemotherapy. Cancer Investigation 2009; 27(7): 741 doi: 10.1080/07357900802672704
|
| 24 |
Toshihiko Maeda, Yasuteru Sano, Masaaki Abe, Fumitaka Shimizu, Yoko Kashiwamura, Sumio Ohtsuki, Tetsuya Terasaki, Masuo Obinata, Masatsugu Ueda, Takashi Kanda. Establishment and characterization of spinal cord microvascular endothelial cell lines. Clinical and Experimental Neuroimmunology 2013; 4(3): 326 doi: 10.1111/cen3.12045
|
| 25 |
Fumitaka Shimizu, Yasuteru Sano, Masa‐aki Abe, Toshihiko Maeda, Sumio Ohtsuki, Tetsuya Terasaki, Takashi Kanda. Peripheral nerve pericytes modify the blood–nerve barrier function and tight junctional molecules through the secretion of various soluble factors. Journal of Cellular Physiology 2011; 226(1): 255 doi: 10.1002/jcp.22337
|
| 26 |
Allison S. Harney, George S. Karagiannis, Jeanine Pignatelli, Bryan D. Smith, Ece Kadioglu, Scott C. Wise, Molly M. Hood, Michael D. Kaufman, Cynthia B. Leary, Wei-Ping Lu, Gada Al-Ani, Xiaoming Chen, David Entenberg, Maja H. Oktay, Yarong Wang, Lawrence Chun, Michele De Palma, Joan G. Jones, Daniel L. Flynn, John S. Condeelis. The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors. Molecular Cancer Therapeutics 2017; 16(11): 2486 doi: 10.1158/1535-7163.MCT-17-0241
|
| 27 |
Inés D. Pousa, Alicia Algaba, Pablo M. Linares, Paloma Sanz-Cameno, José Maté, Ricardo Moreno-Otero, Fernando Bermejo, Javier P. Gisbert. Corticosteroids Modulate Angiogenic Soluble Factors in Ulcerative Colitis Patients. Digestive Diseases and Sciences 2011; 56(3): 871 doi: 10.1007/s10620-010-1327-x
|
| 28 |
Anindita Banerjee, Patrizia Farci. Fibrosis and Hepatocarcinogenesis: Role of Gene-Environment Interactions in Liver Disease Progression. International Journal of Molecular Sciences 2024; 25(16): 8641 doi: 10.3390/ijms25168641
|
| 29 |
Hiroyo Haruki, Yasuteru Sano, Fumitaka Shimizu, Masatoshi Omoto, Ayako Tasaki, Mariko Oishi, Michiaki Koga, Kazuyuki Saito, Toshiyuki Takahashi, Tsutomu Nakada, Takashi Kanda. NMO sera down-regulate AQP4 in human astrocyte and induce cytotoxicity independent of complement. Journal of the Neurological Sciences 2013; 331(1-2): 136 doi: 10.1016/j.jns.2013.05.035
|
| 30 |
Ning Zhang, Lu Wang, Ying Liang, Yi-Ming Zhao, Qiong Xue, Wei-Zhong Wu, Hui-Chuan Sun, Jia Fan, Zhao-You Tang. The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2009; 135(10): 1447 doi: 10.1007/s00432-009-0589-1
|
| 31 |
Inés D. Pousa, José Maté, Xamila Salcedo-Mora, Maria T. Abreu, Ricardo Moreno-Otero, Javier P. Gisbert. Role of vascular endothelial growth factor and angiopoietin systems in serum of Crohnʼs disease patients. Inflammatory Bowel Diseases 2008; 14(1): 61 doi: 10.1002/ibd.20269
|
| 32 |
Smita Kumari, Dia Advani, Sudhanshu Sharma, Rashmi K. Ambasta, Pravir Kumar. Combinatorial therapy in tumor microenvironment: Where do we stand?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(2): 188585 doi: 10.1016/j.bbcan.2021.188585
|
| 33 |
M. CHAPARRO, L. GONZÁLEZ MORENO, M. TRAPERO‐MARUGÁN, J. MEDINA, R. MORENO‐OTERO. Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents. Alimentary Pharmacology & Therapeutics 2008; 28(11-12): 1269 doi: 10.1111/j.1365-2036.2008.03857.x
|
| 34 |
Foteini Economidou, Katerina M. Antoniou, Nikolaos Tzanakis, Katerina Sfiridaki, Nikolaos M. Siafakas, Sofia E. Schiza. Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions. Respiratory Medicine 2008; 102(5): 774 doi: 10.1016/j.rmed.2007.10.021
|
| 35 |
Anuradha Budhu, Junfang Ji, Xin Wei Wang. Hepatocellular Carcinoma. 2009; : 131 doi: 10.1007/978-1-60327-376-3_5
|
| 36 |
R. A. Pazo-Cid, M. Lanzuela, G. Esquerdo, J. L. Pérez-Gracia, A. Antón, G. Amigo, J. Martínez Trufero, A. L. García-Otín, P. Martín-Duque. Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC). Clinical and Translational Oncology 2012; 14(8): 564 doi: 10.1007/s12094-012-0842-y
|
| 37 |
Michael Y. Bonner, Jack L. Arbiser. Clinical and Basic Immunodermatology. 2017; : 165 doi: 10.1007/978-3-319-29785-9_11
|
| 38 |
Antonio Diaz-Sanchez, Ana Matilla, Oscar Nuñez, Raquel Lorente, Alejandro Fernandez, Diego Rincón, Rocio Campos, Rafael Bañares, Gerardo Clemente. Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma. Scandinavian Journal of Gastroenterology 2013; 48(3): 334 doi: 10.3109/00365521.2012.746391
|
| 39 |
Ronnie T. P. Poon, Cecilia Lau, Roberta Pang, Kelvin K. Ng, Jimmy Yuen, Sheung Tat Fan. High Serum Vascular Endothelial Growth Factor Levels Predict Poor Prognosis after Radiofrequency Ablation of Hepatocellular Carcinoma: Importance of Tumor Biomarker in Ablative Therapies. Annals of Surgical Oncology 2007; 14(6): 1835 doi: 10.1245/s10434-007-9366-z
|
| 40 |
Hideaki Nishihara, Fumitaka Shimizu, Yasuteru Sano, Yukio Takeshita, Toshihiko Maeda, Masaaki Abe, Michiaki Koga, Takashi Kanda, Akio Suzumura. Fingolimod Prevents Blood-Brain Barrier Disruption Induced by the Sera from Patients with Multiple Sclerosis. PLOS ONE 2015; 10(3): e0121488 doi: 10.1371/journal.pone.0121488
|
| 41 |
Thomas Yau, Pierre Chan, Richard Epstein, Ronnie Tung Ping Poon. Management of advanced hepatocellular carcinoma in the era of targeted therapy. Liver International 2009; 29(1): 10 doi: 10.1111/j.1478-3231.2008.01916.x
|
| 42 |
Koji Miyahara, Kazuhiro Nouso, Takeshi Tomoda, Sayo Kobayashi, Hiroaki Hagihara, Kenji Kuwaki, Junichi Toshimori, Hideki Onishi, Fusao Ikeda, Yasuhiro Miyake, Shinichiro Nakamura, Hidenori Shiraha, Akinobu Takaki, Kazuhide Yamamoto. Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2011; 26(11): 1604 doi: 10.1111/j.1440-1746.2011.06887.x
|
| 43 |
Fumitaka Shimizu, Yasuteru Sano, Kazuyuki Saito, Masa-aki Abe, Toshihiko Maeda, Hiroyo Haruki, Takashi Kanda. Pericyte-derived Glial Cell Line-derived Neurotrophic Factor Increase the Expression of Claudin-5 in the Blood–brain Barrier and the Blood-nerve Barrier. Neurochemical Research 2012; 37(2): 401 doi: 10.1007/s11064-011-0626-8
|
| 44 |
Andrew X Zhu, Eric Raymond. Early development of sunitinib in hepatocellular carcinoma. Expert Review of Anticancer Therapy 2009; 9(1): 143 doi: 10.1586/14737140.9.1.143
|
| 45 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_186-1
|
| 46 |
Silvia Affo, Le-Xing Yu, Robert F. Schwabe. The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer. Annual Review of Pathology: Mechanisms of Disease 2017; 12(1): 153 doi: 10.1146/annurev-pathol-052016-100322
|
| 47 |
Zhen Fan Yang, Ronnie T.P. Poon. Vascular Changes in Hepatocellular Carcinoma. The Anatomical Record 2008; 291(6): 721 doi: 10.1002/ar.20668
|
| 48 |
Kazuyuki Saito, Fumitaka Shimizu, Michiaki Koga, Yasuteru Sano, Ayako Tasaki, Masaaki Abe, Hiroyo Haruki, Toshihiko Maeda, Seiko Suzuki, Susumu Kusunoki, Hidehiro Mizusawa, Takashi Kanda. Blood–brain barrier destruction determines Fisher/Bickerstaff clinical phenotypes: an in vitro study. Journal of Neurology, Neurosurgery & Psychiatry 2013; 84(7): 756 doi: 10.1136/jnnp-2012-304306
|
| 49 |
U. N. Tumanova, A. I. Shchegolev. Angiogenesis in hepatocellular carcinoma. Biology Bulletin Reviews 2015; 5(6): 568 doi: 10.1134/S2079086415060080
|
| 50 |
Ratna Kumari, Manoj Kumar Sahu, Anindita Tripathy, Kanishka Uthansingh, Manas Behera. Hepatocellular carcinoma treatment: hurdles, advances and prospects. Hepatic Oncology 2018; 5(2) doi: 10.2217/hep-2018-0002
|
| 51 |
Jing Zheng, Xue Qin Gong, Yun Yun Tao, Ran Wang, Gang Yang, Jing Dong Li, Tian Ren, Zu Mao Li, Cui Yang, Wei Cheng Wang, Lin Yang, Xiao Ming Zhang. A Correlative Study Between IVIM-DWI Parameters and the Expression Levels of Ang-2 and TKT in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.594366
|
| 52 |
Ying-zhi ZHOU, Xue-qiang FANG, Hao LI, Yu-tao DIAO, Yan-fang YANG, De-li ZHAO, Kan WU, Hui-qing LI. Role of serum angiopoietin-2 level in screening for esophageal squamous cell cancer and its precursors. Chinese Medical Journal 2007; 120(14): 1216 doi: 10.1097/00029330-200707020-00002
|
| 53 |
Satoshi Kuboki, Hiroaki Shimizu, Noboru Mitsuhashi, Kimihiko Kusashio, Fumio Kimura, Hiroyuki Yoshidome, Masayuki Ohtsuka, Atsushi Kato, Hideyuki Yoshitomi, Masaru Miyazaki. Angiopoietin‐2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2008; 23(7pt2) doi: 10.1111/j.1440-1746.2007.05175.x
|
| 54 |
María Chaparro, Paloma Sanz-Cameno, María Trapero-Marugán, Luisa García-Buey, Ricardo Moreno-Otero. Mechanisms of angiogenesis in chronic inflammatory liver disease. Annals of Hepatology 2007; 6(4): 208 doi: 10.1016/S1665-2681(19)31900-3
|
| 55 |
Charles S Harmon, Samuel E DePrimo, Eric Raymond, Ann-Lii Cheng, Eveline Boucher, Jean-Yves Douillard, Ho Y Lim, Jun S Kim, Maria José Lechuga, Silvana Lanzalone, Xun Lin, Sandrine Faivre. Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib. Journal of Translational Medicine 2011; 9(1) doi: 10.1186/1479-5876-9-120
|
| 56 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3443 doi: 10.1007/978-3-319-26956-6_186
|
| 57 |
Dianne H. Dapito, Robert F. Schwabe. Stellate Cells in Health and Disease. 2015; : 145 doi: 10.1016/B978-0-12-800134-9.00009-9
|
| 58 |
Yuya Sato, Hidenori Ojima, Hiroaki Onaya, Taisuke Mori, Nobuyoshi Hiraoka, Yoji Kishi, Satoshi Nara, Minoru Esaki, Kazuaki Shimada, Tomoo Kosuge, Kenich Sugihara, Yae Kanai. Histopathological characteristics of hypervascular cholangiocellular carcinoma as an early stage of cholangiocellular carcinoma. Hepatology Research 2014; 44(11): 1119 doi: 10.1111/hepr.12236
|
| 59 |
Ji-An Chen, Ming Shi, Jin-Qing Li, Chao-Nan Qian. Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration. Hepatology International 2010; 4(3): 537 doi: 10.1007/s12072-010-9192-4
|
| 60 |
Hiroshi Nishiura, Mai Imasaka, Koji Yamanegi, Jiro Fujimoto, Masaki Ohmuraya. Immune Aging and How It Works for Inflammation and Fibrosis. Frontiers in Physiology 2022; 12 doi: 10.3389/fphys.2021.795508
|
| 61 |
ZHONG-LIN ZHANG, JI-FA ZHANG, YU-FENG YUAN, YUE-MING HE, QUAN-YAN LIU, XIAO-WEN MAO, YONG-BIAO AI, ZHI-SU LIU. Suppression of angiogenesis and tumor growth in vitro and in vivo using an anti-angiopoietin-2 single-chain antibody. Experimental and Therapeutic Medicine 2014; 7(3): 543 doi: 10.3892/etm.2014.1476
|
| 62 |
Thomas Yau, Roberta Pang, Pierre Chan, Ronnie T Poon. Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib. Expert Opinion on Pharmacotherapy 2010; 11(13): 2187 doi: 10.1517/14656561003724705
|
| 63 |
LILI ZHANG, SU YU, ZHIJUN DUAN, QIUMING WANG, GE TIAN, YAN TIAN, WEI ZHAO, HUI WANG, CUILING ZHANG, SHIBIN GUO, QIGUI LIU, GAOHONG HE, TENGFEI BIAN, JIUYANG CHANG, XUE JIN, DONGSHENG CUI. Treatment of liver cancer in mice by the intratumoral injection of an octreotide-based temperature-sensitive gel. International Journal of Molecular Medicine 2014; 33(1): 117 doi: 10.3892/ijmm.2013.1542
|